AtriCure (ATRC) Share-based Compensation (2010 - 2026)

AtriCure (ATRC) has reported Share-based Compensation for 17 consecutive years, with $12.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 12.14% year-over-year to $12.1 million in Q2 2026; TTM through Jun 2026 was $47.3 million, a 13.22% increase from a year earlier, with the FY2025 full-year figure at $44.7 million, up 10.59% from the prior year.
• Share-based Compensation was $12.1 million for Q2 2026 at AtriCure, up from $11.4 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $12.4 million in Q3 2025 and troughed at $3.9 million in Q2 2022.
• A 5-year average of $9.6 million and a median of $10.3 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation plunged 61.24% in 2022 and jumped 128.42% in 2023, its largest moves.
• Over 5 years, Share-based Compensation stood at $7.2 million in 2022, then gained by 29.39% to $9.3 million in 2023, then advanced by 11.52% to $10.4 million in 2024, then rose by 8.43% to $11.3 million in 2025, then increased by 7.85% to $12.1 million in 2026.
• The last three Share-based Compensation figures came in at $12.1 million (Q2 2026), $11.4 million (Q1 2026), and $11.3 million (Q4 2025), per Business Quant data.